Skip to main content
FinSpry Logo
FinSpry
NPCE logo
NPCE
(NASDAQ)
NeuroPace, Inc.
$14.03-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

NeuroPace (NPCE) Stock Price & Financial Analysis

NeuroPace Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$14.18 - $14.68
52-Week High$19.60
52-Week Low$8.17
Open$14.58
Volume197.41K
Average Volume (3M)208.96K
Market Cap493.61M
Shares Outstanding33.72M
Price to Sales (P/S)4.84
Price to Book (P/B)33.31
EV/EBITDA-38.81
Revenue (TTM)99.53M
Net Income (TTM)-21.57M
Free Cash Flow (TTM)-9.84M
EPS (TTM)$-0.65
Profit Margin-21.67%
Operating Margin-16.84%
Return on Equity (ROE)-149.20%
Debt to Equity4.87
50-Day MA$15.45
200-Day MA$15.30
52-Week Change66.82%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About NeuroPace

What is the current stock price for NPCE?

As of the latest trading session, NPCE stock trades at $14.28. The 52-week range is $8.17–$19.60, with a day range of $14.18–$14.68.

What is the P/E ratio for NPCE?

The P/E ratio (Price-to-Earnings) for NPCE is shown in the Key Statistics section. This valuation metric helps compare NeuroPace, Inc. to industry peers.

Does NPCE pay dividends?

NeuroPace does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for NPCE?

Based on 2 analysts, the consensus for NPCE is Buy.

What is the market cap of NPCE?

NeuroPace's market capitalization is $481.5M, classifying it as a small-cap company. NeuroPace operates in the Healthcare sector within the Medical Devices industry.